WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
RSV immunisation for babies: Doctors call for urgent accessChina pushes emergency use of COVID vaccine despite concernsMāori portrait to return from UK after decadesCalifornia doctor with cancer gets rare lungTrump hawks $399 branded shoes at Sneaker Con, a day after a $355 million ruling against himVaccine maker becomes China's richest man after wealth increases fiftyRogue digital billboard making fun of Waka Kotahi removedChinese President Xi Jinping sends a message of sympathy to Donald TrumpAuckland bus services disrupted by police search warrantArrests made after Lower Hutt siblings hospitalised with severe injuries
0.2038s , 6500.6875 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,International Investigation news portal